SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 119 filers reported holding SANA BIOTECHNOLOGY INC in Q4 2022. The put-call ratio across all filers is 7.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,024,965 | -35.1% | 3,365,624 | 0.0% | 1.52% | -27.6% |
Q2 2023 | $20,059,119 | +91.0% | 3,365,624 | +4.8% | 2.10% | +68.0% |
Q1 2023 | $10,499,764 | -21.0% | 3,210,937 | -4.6% | 1.25% | -36.0% |
Q4 2022 | $13,294,215 | -34.2% | 3,365,624 | 0.0% | 1.95% | -28.6% |
Q3 2022 | $20,194,000 | -6.7% | 3,365,624 | 0.0% | 2.73% | -3.3% |
Q2 2022 | $21,641,000 | -18.4% | 3,365,624 | +4.8% | 2.82% | -11.2% |
Q1 2022 | $26,522,000 | -46.6% | 3,210,937 | 0.0% | 3.18% | -14.4% |
Q4 2021 | $49,705,000 | -31.3% | 3,210,937 | 0.0% | 3.71% | -45.4% |
Q3 2021 | $72,310,000 | +14.5% | 3,210,937 | 0.0% | 6.80% | +24.9% |
Q2 2021 | $63,127,000 | – | 3,210,937 | – | 5.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 34,239,018 | $673,139,000 | 8.60% |
Trustees of Columbia University in the City of New York | 281,250 | $5,530,000 | 8.17% |
Crestline Management, LP | 3,210,937 | $63,127,000 | 5.44% |
Omega Fund Management, LLC | 843,750 | $16,588,000 | 1.88% |
Alphabet Inc. | 2,812,500 | $55,294,000 | 1.13% |
SB Management Ltd | 2,625,153 | $51,611,000 | 0.61% |
PUBLIC SECTOR PENSION INVESTMENT BOARD | 4,508,111 | $88,629,000 | 0.53% |
HARVARD MANAGEMENT CO INC | 468,749 | $9,216,000 | 0.53% |
Avidity Partners Management LP | 778,597 | $15,307,000 | 0.41% |
Dragoneer Investment Group | 1,500,000 | $29,490,000 | 0.38% |